🔴 Nanobiotix is trading 5.9% down in pre-market as Nasdaq futures fall 1.78%

Nanobiotix is trading 5.88% down now at $34.83 after opening September 14, 2026, amid a weaker market backdrop.

• Nasdaq futures were down 1.78%, with investors focused on Tuesday’s Federal Reserve decision, higher oil, geopolitical concerns, and technology-sector selling.
• Separately, Nanobiotix announced positive Phase 1 results for JNJ-1900, including 79% one-year locoregional control and no treatment-related Grade 3 or higher adverse events; the release does not establish a cause for the pre-market decline.